×

Europe

f9a57bfe-51c7-11e9-8939-5623721d3707

Europe’s pragmatic approach to clinical evidence for legacy devices – or why the devil is always in the detail…

By Arthur Brandwood | 03.30.2019
Regulatory affairs demand attention to detail. So when the European Medical Devices Coordination Group released document MDCG 2019-3 - Interpretation of Article 54(2)b we regulatory geeks just knew we should...
TrainXstation

Halfway there? Will the MDR/IVDR train arrive on time – and what about Brexit?

By Luis Jimenez | 12.03.2018
As the implementation journey for the EU MDR/IVDR passes the halfway point, we provide an update to the current state of play and the impact on our industry. Many, if...

Search

Recent Posts

TGA Regulatory Business Plan 2019-2020

Oct 1, 2019

Breast implants and anaplastic large cell lymphoma

Oct 1, 2019

Update on Implant Card Requirements

Sep 25, 2019

Custom Devices, Clinical Trials and the Hazards of Precedent

Sep 2, 2019

Make your transition from MDD to MDR – White Paper

Aug 30, 2019

EVIDENCE MATTERS: for new and established medicines

Aug 26, 2019

Categories

Categories

Archives

Archives

Archives

Tags

3D 3D printing 510(k) adverse events Apple Watch Artificial Intelligence Australia Biocompatibility Biomechanics Brexit CE CE Certificates CFDA China distribution Europe FDA Health Canada IVD IVDR MDD MDR MDSAP mechanical properties medical device medical devices New Zealand Notified Bodies PMA PMDA post market postmarket private health insurance QMS Quality Systems Reform regulatory Reimbursement SaMD Software standards Sterilisation TGA UDI Webinar
Translate »